BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9002302)

  • 1. Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor.
    Shichino H; Mugishima H; Takamura M; Shimada T; Suzuki T; Chin M; Harada K; Ryo S; Kojima S
    Acta Paediatr Jpn; 1996 Dec; 38(6):644-7. PubMed ID: 9002302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
    Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
    Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
    Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
    Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
    Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of anti-thymocyte globulin and cyclosporin A combined therapy in aplastic anemia complicated with limited cutaneous systemic sclerosis].
    Suematsu E; Miyamura T; Idutsu K; Minami R; Yamamoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Apr; 28(2):99-103. PubMed ID: 15863969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe aplastic anemia remarkably improved by a treatment with antilymphocyte globulin, high-dose methylprednisolone and danazol].
    Miyamura K; Kojima S; Takeyama K; Matsushita T; Minami S; Kodera Y
    Rinsho Ketsueki; 1989 Jan; 30(1):72-7. PubMed ID: 2716202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
    Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
    N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment with combination of methylprednisolone, antilymphocyte globulin and cyclosporine in two cases of aplastic anemia].
    Ishikawa Y; Arioka H; Kobayashi R; Naito H
    Rinsho Ketsueki; 1992 Nov; 33(11):1697-702. PubMed ID: 1469786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Time course changes in the count of peripheral granulocytes in children with acquired aplastic anemias treated with antithymocyte globulin, cyclosporin A and granulocytic colony stimulating factor].
    Bogacheva NIu; Novichkova GA; Litvinov DV; Khachatrian LA; Baĭdil'dina DD; Shneĭder MM; Suntsova EV; Skorobogatova EV; Maschan AA
    Ter Arkh; 2002; 74(12):71-7. PubMed ID: 12577848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
    Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
    Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Schrezenmeier H; Socié G; Marsh J; Bacigalupo A; Dührsen U; Franzke A; Hallek M; Thiel E; Wilhelm M; Höchsmann B; Barrois A; Champion K; Passweg JR
    Blood; 2011 Apr; 117(17):4434-41. PubMed ID: 21233311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
    Kanakura M; Mihara H; Wakabayashi M; Tajima E; Hiramatsu A; Sato A; Imamura A; Miwa H; Kato Y; Nitta M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):1036-8. PubMed ID: 11985078
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
    Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F
    Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
    Meidlinger P; Knöbl P; Jäger U; Gisslinger H; Pabinger I; Weltermann A; Lechner K; Geissler K
    Ann Hematol; 1999 Jul; 78(7):299-304. PubMed ID: 10466441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.